Arbutus Biopharma Corporation Common Stock (ABUS) is a publicly traded Healthcare sector company. As of July 8, 2026, ABUS trades at $5.26 with a market cap of $981.76M and a P/E ratio of 6.24. ABUS moved +4.02% today. Year to date, ABUS is +12.12%; over the trailing twelve months it is +64.97%. Its 52-week range spans $2.71 to $5.34. Rallies surfaces ABUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ABUS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $5.26 |
| Market Cap | $981.76M |
| P/E Ratio | 6.24 |
| EPS | $0.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.34 |
| 52-Week Low | $2.71 |
| Volume | 4.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $191.44M |
| Net Income | $160.72M |
| Gross Margin | 0.00% |
ABUS analyst coverage data. Average price target: $0.00.